v3.26.1
Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
Class A
Ordinary Shares
Class B
Ordinary Shares
Subscription receivable
Additional paid-in capital
Statutory reserves
Retained earnings
Accumulated other comprehensive (loss)/income
Total
Balance at Mar. 31, 2023 $ 2,500 $ 2,500 $ (5,000) $ 1,236,773 $ 813,235 $ 9,786,946 $ (1,345,687) $ 10,491,267
Balance (in Shares) at Mar. 31, 2023 [1] 500,000 500,000            
Net loss (1,295,163) (1,295,163)
Capital injection by shareholder 5,000 5,000
Issuance of ordinary shares, net of issuance cost $ 791 3,619,022 3,619,813
Issuance of ordinary shares, net of issuance cost (in Shares) [1] 158,125            
Foreign currency translation (523,250) (523,250)
Balance at Mar. 31, 2024 $ 3,291 $ 2,500   4,855,795 813,235 8,491,783 (1,868,937) 12,297,667
Balance (in Shares) at Mar. 31, 2024 [1] 658,125 500,000            
Net loss (1,410,465) (1,410,465)
Foreign currency translation (161,106) (161,106)
Balance at Mar. 31, 2025 $ 3,291 $ 2,500 4,855,795 813,235 7,081,318 (2,030,043) 10,726,096
Balance (in Shares) at Mar. 31, 2025 [1] 658,125 500,000            
Net loss (4,805,561) (4,805,561)
Issuance of ordinary shares, net of issuance cost $ 5,883 6,335,007 6,340,890
Issuance of ordinary shares, net of issuance cost (in Shares) [1] 1,176,663              
Cashless exercise of warrants $ 7,894 (7,894)
Cashless exercise of warrants (in Shares) [1] 1,578,732              
Foreign currency translation 430,117 430,117
Balance at Mar. 31, 2026 $ 17,068 $ 2,500 $ 11,182,908 $ 813,235 $ 2,275,757 $ (1,599,926) $ 12,691,542
Balance (in Shares) at Mar. 31, 2026 [1] 3,413,520 500,000            
[1] Retrospectively restated for effect of the share consolidation completed in January 2026 (see Note 14).